Copyright
©The Author(s) 2021.
World J Gastroenterol. Aug 28, 2021; 27(32): 5362-5375
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5362
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5362
Table 2 Changes in microbiota composition associated with anti-cytotoxic T-lymphocyte-associated protein 4 efficacy treatment against cancer and potential strategies for improving efficacy
Models | Disease | Implicated microbiota | New strategies | Implicated microbiota | Ref. |
Mice | MCA205 sarcomas | Clostridiales↑, Bacteroides thetaiotaomicron↑, B. uniformis↑, Bacteroidales↓, Burkholderiales↓, | (1) B. thetaiotaomicron; (2) B fragilis; and (3) Burkholderia cepacia | NO | Vétizou et al[70], 2015 |
Mice | CRC | NO | Lactobacillus acidophilus cell lysates | NO | Zhuo et al[73], 2019 |
Mice | CRC | NO | (1) Bifidobacterium pseudolongum; (2) Lactobacillus johnsonii; (3) Olsenella spp; and (4) Metabolite inosine | NO | Mager et al[74], 2020 |
Huamn | Melanoma | Faecalibacterium genus↑, unclassified Ruminococcus↑, Lachnospiraceae genus↑, Clostridium XIVa↑, Blautia↑, Butyrate producing bacterium↑, Gemmiger formicilis↑, Bacteroides↓, B. fragilis↓, B. thetaiotaomicron↓ | NO | NO | Chaput et al[72], 2017 |
- Citation: Kang YB, Cai Y. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer. World J Gastroenterol 2021; 27(32): 5362-5375
- URL: https://www.wjgnet.com/1007-9327/full/v27/i32/5362.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i32.5362